The Arg389Gly β 1-adrenoceptor gene polymorphism influences the acute effects of β-adrenoceptor blockade on contractility in the human heart

Clinical Research in Cardiology

Volumn 100, Issue 8, 2011, Pages 641-647

  Huntgeburth, Michael ^a   La Rosée, Karl ^a   Ten Freyhaus, Henrik ^a   Böhm, Michael ^b   Schnabel, Petra ^a   Hellmich, Martin ^a   Rosenkranz, Stephan ^a  

^a UNIVERSITY OF COLOGNE   (Germany)

^b SAARLAND UNIVERSITY   (Germany)

Author keywords

Blocker; 1 Adrenoceptor; Arg389Gly; Contractility; Gene polymorphism

Indexed keywords

ATROPINE; BETA 1 ADRENERGIC RECEPTOR; CATECHOLAMINE; DOBUTAMINE; METOPROLOL; METOPROLOL TARTRATE;

ADULT; ALLELE; ARTICLE; CONTROLLED RELEASE FORMULATION; DNA POLYMORPHISM; DRUG RELEASE; FEMALE; GENOTYPE; HEART AFTERLOAD; HEART CONTRACTION; HEART MUSCLE CELL; HEART PRELOAD; HEART RATE; HEART VENTRICLE CONTRACTILITY; HOMOZYGOSITY; HUMAN; MALE; RECEPTOR BLOCKING; SINGLE NUCLEOTIDE POLYMORPHISM; STRESS ECHOCARDIOGRAPHY; VELOCITY; VOLUNTEER;

ADRENERGIC BETA-1 RECEPTOR ANTAGONISTS; ADULT; ARGININE; ECHOCARDIOGRAPHY, STRESS; GENOTYPE; GLYCINE; HUMANS; MALE; METOPROLOL; MYOCARDIAL CONTRACTION; POLYMERASE CHAIN REACTION; POLYMORPHISM, SINGLE NUCLEOTIDE; RECEPTORS, ADRENERGIC, BETA-1; VENTRICULAR FUNCTION, LEFT;

EID: 80051798314     PISSN: 18610684     EISSN: 18610692     Source Type: Journal    
DOI: 10.1007/s00392-011-0288-1     Document Type: Article

References (31)

1. D Kaye M Esler 2005 Sympathetic neuronal regulation of the heart in aging and heart failure Cardiovasc Res 66 256 264 15820194 10.1016/j.cardiores.2005. 02.012 1:CAS:528:DC%2BD2MXivFyqt74%3D (Pubitemid 40471040)
2. K Leineweber G Heusch 2009 Beta 1- and beta 2-adrenoceptor polymorphisms and cardiovascular diseases Br J Pharmacol 158 61 69 19422376 10.1111/j.1476-5381.2009.00187.x 1:CAS:528:DC%2BD1MXhsVKmu7bM
3. J Shin JA Johnson 2010 β-Blocker pharmacogenetics in heart failure Heart Fail Rev 15 187 196 18437562 10.1007/s10741-008-9094-x 1:CAS:528:DC%2BC3cXksVeisL0%3D
4. AM Nia E Caglayan N Gassanov, et al. 2010 Beta1-adrenoceptor polymorphism predicts flecainide action in patients with atrial fibrillation PLoS ONE 5 7 e11421 20625396 10.1371/journal.pone.0011421
5. 1-adrenergic receptor J Biol Chem 274 12670 12674 10212248 10.1074/jbc.274.18.12670 1:CAS:528:DyaK1MXjtFGnsrk%3D (Pubitemid 29215505)
6. 1-adrenergic receptor Proc Natl Acad Sci USA 84 7920 7924 2825170 10.1073/pnas.84.22.7920 1:CAS:528:DyaL1cXhsVCns7s%3D (Pubitemid 17162813)
7. 1-adrenoceptor: identification and rapid screening assay Lancet 353 897 10093986 10.1016/S0140-6736(99)00549-8 1:CAS:528:DyaK1MXitFChsLw%3D (Pubitemid 29126881)
8. 1-adrenoceptor gene polymorphism determines contractile response to catecholamines Pharmacogenetics 14 711 716 15564877 10.1097/00008571-200411000-00001 (Pubitemid 39552785)
9. SA Hunt WT Abraham MT Chin, et al. 2005 ACC/AHA 2005 guideline update for the diagnosis and management of chronic heart failure in the adult Circulation 112 e154 e235 16160202 10.1161/CIRCULATIONAHA.105.167586
10. M Gheorgiade WS Colucci K Swedberg 2003 β-blockers in chronic heart failure Circulation 107 1570 1575 10.1161/01.CIR.0000065187.80707.18 (Pubitemid 36397322)
11. H Bruck K Leineweber T Temme M Weber G Heusch T Philipp O-E Brodde 2005 The Arg389Gly beta1-adrenoceeptor polymorphism and catecholamine effects on plasma-renin activity J Am Coll Cardiol 46 2111 2115 16325050 10.1016/j.jacc.2005.08.041 1:CAS:528:DC%2BD2MXht1Onur7K (Pubitemid 41713600)
12. WF Armstrong PA Pellikka T Ryan, et al. 1998 Stress echocardiography: recommendations for performance and interpretation of stress echocardiography J Am Soc Echocardiogr 11 97 104 9487482 10.1016/S0894-7317(98)70132-4 1:STN:280:DyaK1c7kvVClsA%3D%3D (Pubitemid 28158541)
13. SD Colan KM Borow A Neumann 1984 Left ventricular end-systolic wall stress-velocity of fiber shortening relation: a load-independent index of myocardial contractility J Am Coll Cardiol 4 715 724 6207218 10.1016/S0735-1097(84)80397-6 1:STN:280:DyaL2M%2FgslyrsA%3D%3D (Pubitemid 14012458)
14. MD Cheitlin JS Alpert WF Armstrong, et al. 1997 ACC/AHA guidelines for the clinical application of echocardiography: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Clinical Application of Echocardiography) developed in collaboration with the American Society of Echocardiography Circulation 95 6 1686 1744 9118558 1:STN:280:DyaK2s3jsVSmuw%3D%3D (Pubitemid 27142849)
15. 1-adrenoceptor does not influence blood pressure or heart rate response to beta-blockade in hypertensive subjects Clin Sci (Lond) 99 233 238 10.1042/CS20000030
16. P De Groote N Helbecque N Lamblin, et al. 2005 Association between beta-1 and beta-2 adrenergic receptor gene polymorphisms and the response to beta-blockade in patients with stable congestive heart failure Pharmacogenet Genomics 15 137 142 15861037 10.1097/01213011-200503000-00001 (Pubitemid 40569899)
17. J Liu ZQ Liu ZR Tan, et al. 2003 Gly389Arg polymorphism of beta1-adrenergic receptor is associated with the cardiovascular response to metoprolol Clin Pharmacol Ther 74 4 372 379 14534524 10.1016/S0009-9236(03) 00224-8 1:CAS:528:DC%2BD3sXnvVyks74%3D (Pubitemid 37222858)
18. Kindermann M, Seeland U, Ruhnke P, Böhm M, Maack C (2011) Functional effects of beta(1)-adrenoceptor polymorphisms on the hemodynamic responses to dobutamine with an without beta-blocker administration. Clin Res Cardiol 100(2):129-137
19. JP Curtis SI Sokol Y Wang, et al. 2003 The association of left ventricular ejection fraction, mortality, and cause of death in stable outpatients with heart failure J Am Coll Cardiol 42 736 742 12932612 10.1016/S0735-1097(03)00789-7 (Pubitemid 37000196)
20. SG Terra KK Hamilton DF Pauly, et al. 2005 β1-adrenergic receptor polymorphisms and left ventricular remodeling changes in response to β-blocker therapy Pharmacogenet Genomics 15 227 234 15864115 10.1097/01213011-200504000-00006 1:CAS:528:DC%2BD2MXpslOmsbc%3D (Pubitemid 40569894)
21. 1-adrenergic receptor polymorphisms confer differential function and predisposition to heart failure Nat Med 9 1300 1305 10.1038/nm930 1:CAS:528:DC%2BD3sXns1Clu7s%3D (Pubitemid 37279854)
22. HL White RA de Boer A Maqbool D Greenwood DJ van Veldhuisen R Cuthbert SG Ball AS Hall AJ Balmforth MERIT-HF Study Group 2003 An evaluation of the beta-1 adrenergic receptor Arg389Gly polymorphism in individuals with heart failure: A MERIT-HF sub-study Eur J Heart Fail 5 4 463 468 12921807 10.1016/S1388-9842(03) 00044-8 1:CAS:528:DC%2BD3sXmt1Kitb4%3D (Pubitemid 37021640)
23. J Savva A Maqbool HL White SL Galloway NY Yuldasheva SG Ball RM West RA De Boer DJ Van Veldhuisen AJ Balmforth Merit-HF Study Group 2009 Polymorphisms of adrenoceptors are not associated with an increased risk of adverse event in heart failure: a MERIT-HF substudy J Card Fail 15 5 435 441 19477404 10.1016/j.cardfail.2008.12.005 1:CAS:528:DC%2BD1MXms1ygs74%3D
24. AJ Sehnert SE Daniels M Elashoff, et al. 2008 Lack of association between adrenergic receptor genotypes and survival in heart failure patients treated with carvedilol or metoprolol Am Coll Cardiol 52 8 644 651 10.1016/j.jacc.2008. 05.022 1:CAS:528:DC%2BD1cXpvFGgt7c%3D
25. L Chen D Meyers G Javorsky, et al. 2007 Arg389Gly-beta1-adrenergic receptors determine improvement in left ventricular systolic function in nonischemic cardiomyopathy patients with heart failure after chronic treatment with carvedilol Pharmacogenet Genomics 17 11 941 949 18075464 10.1097/FPC.0b013e3282ef7354 1:CAS:528:DC%2BD2sXht1Knt73E (Pubitemid 350293794)
26. SB Liggett J Mialet-Perez S Thaneemit-Chen, et al. 2006 A polymorphism within a conserved beta(1)-adrenergic receptor motif alters cardiac function and beta-blocker response in human heart failure Proc Natl Acad Sci USA 103 11288 11293 16844790 10.1073/pnas.0509937103 1:CAS:528:DC%2BD28XnvValtbc%3D (Pubitemid 44156511)
27. MT Lobmeyer Y Gong SG Terra, et al. 2007 Synergistic polymorphisms of beta1 and alpha2C-adrenergic receptors and the influence on left ventricular ejection fraction response to beta-blocker therapy in heart failure Pharmacogenet Genomics 17 4 277 282 17496726 10.1097/FPC.0b013e3280105245 1:CAS:528:DC%2BD2sXjvFCmu74%3D (Pubitemid 46668051)
28. SG Terra DF Pauly CR Lee, et al. 2005 β-Adrenergic receptor polymorphisms and responses during titration of metoprolol controlled release/extended release in heart failure Clin Pharmacol Ther 77 3 127 137 15735607 10.1016/j.clpt.2004.10.006 1:CAS:528:DC%2BD2MXhsVyrsr8%3D (Pubitemid 40269128)
29. I Zineh AL Beitelshees A Gaedigk, et al. 2004 Pharmacokinetics and CYP2D6 genotypes do not predict metoprolol adverse events or efficacy in hypertension Clin Pharmacol Ther 76 536 544 15592325 10.1016/j.clpt.2004.08.020 1:CAS:528:DC%2BD2cXhtVKlt7rK (Pubitemid 39601544)
30. R Fux K Morike AM Prohmer, et al. 2005 Impact of CYP2D6 genotype on adverse effects during treatment with metoprolol: a prospective clinical study Clin Pharmacol Ther 78 378 387 16198657 10.1016/j.clpt.2005.07.004 1:CAS:528:DC%2BD2MXhtVGrsb7I (Pubitemid 41393673)
31. T Rau H Wuttke LM Michels, et al. 2009 Impact of the CYP2D6 genotype on the clinical effects of metoprolol: A prospective longitudinal study Clin Pharmacol Ther 85 3 269 272 19037197 10.1038/clpt.2008.218 1:CAS:528: DC%2BD1MXit1Oguro%3D